Yahoo Web Search

Sign In

  1. Also Try

Search results

  1. uk.investing.com › news › company-newsVerve Therapeutics expands board, appoints two new directors

    1 day ago · The company has made key appointments including Nia Tatsis, Ph.D., and Jodie Morrison to its board of directors, and Troy Lister, Ph.D., as the new Chief Scientific Officer. These strategic changes come as Verve Therapeutics advances its clinical trials, including the Heart-2 trial of VERVE-102 and the upcoming trial of VERVE-201.

  2. in.investing.com › news › company-newsVerve Therapeutics expands board with two appointments

    1 day ago · Tatsis is the current executive vice president and chief regulatory and quality officer at Vertex Pharmaceuticals (NASDAQ: VRTX), while Ms. Morrison is the CEO and director of Q32 Bio Inc.

  3. Videos

    View all

  4. www.medscape.org › viewarticle › 1001274Decoding Schizophrenia -- Muscarinic System Insights: A...

    11 minutes ago · The overall goal of this initiative is for clinicians to understand historic unmet needs in treatment for patients with schizophrenia, recognize the evidence and clinical potential of emerging antipsychotic treatments that target muscarinic receptors in schizophrenia, and realize where emerging therapies may fit into future treatment paradigms.

  5. ph.investing.com › news › company-newsUBS lifts Alnylam Pharma stock target, keeps Buy rating on...

    1 day ago · ALNY. 0.75%. On Friday, UBS increased its price target for Alnylam Pharmaceuticals (NASDAQ:ALNY) to $288 from the previous $253, while reiterating its Buy rating on the company's stock. The revision follows the release of the HELIOS-B study data, which the firm believes strengthens the case for Alnylam's vutrisiran in the treatment of ATTR-CM ...

  6. es.investing.com › news › company-newsVerve Therapeutics amplía su consejo de administración y nombra a...

    1 day ago · Aun así, cabe señalar que Verve Therapeutics firmó un Acuerdo Estratégico de Colaboración y Licencia con Vertex en julio de 2022, que incluye términos financieros significativos, como pagos ...

  7. www.ultimahora.es › noticias › sociedadFibrosis Quística | La Fundación Respiralia nada contra la...

    1 day ago · Este evento solidario cuenta con el patrocinio de Vertex Pharmaceuticals, Linde, Alcampo, el Consell Insular de Formentera y Greystar. Asociación Balear de Fibrosis Quística;

  8. fr.investing.com › news › company-newsVerve Therapeutics élargit son conseil d'administration et nomme...

    1 day ago · Il convient toutefois de noter que Verve Therapeutics a conclu un accord de collaboration stratégique et de licence avec Vertex en juillet 2022, qui comprend des conditions financières importantes telles que des paiements initiaux, des paiements de succès, des étapes de développement, des étapes commerciales et des redevances sur les ventes nettes.